# Health Evaluation in African Americans Using RAS Therapy

> **NCT02471833** · PHASE1,PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 61 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Telmisartan 20mg
- **DRUG:** Telmisartan 40mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02471833
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2022-04-15
- **Final completion:** 2022-04-15
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2024-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02471833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02471833, "Health Evaluation in African Americans Using RAS Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02471833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*